Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator.
Vanlandschoot
Peter
P
Van Houtte
Freya
F
Serruys
Benedikte
B
Leroux-Roels
Geert
G
D000276:Adjuvants, Immunologic / Q000302:isolation & purification; D001402:B-Lymphocytes / Q000276:immunology* / Q000821:virology; D004340:Drug Contamination; D006512:Hepatitis B Core Antigens / Q000235:genetics / Q000302:isolation & purification; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D019590:Nucleocapsid Proteins / Q000235:genetics* / Q000276:immunology* / Q000302:isolation & purification; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D006512:Hepatitis B Core Antigens; D019590:Nucleocapsid Proteins; D011994:Recombinant Proteins